title: [Strontium-89 diagnosis and therapy of bone metastases].
abstract: A clinical test of strontium-89 chloride effect was carried out in 150 patients with bone metastases and bone pain from different patterns of tumor. Different types of bone lesions were considered. Pain-relieving effect was reported in 77%, irrespective of lesion gravity. There was no response to strontium-89 chloride in 150 patients with bone metastases. It mostly occurred in cases of lysis. Strontium-89 chloride therapy contributed to partial bone tissue repair. It is indicated as a component of complex treatment for bone metastases.
authors.forename: A D
authors.initials: AD
authors.lastname: Ryzhkov
authors.forename: R I
authors.initials: RI
authors.lastname: Gabuniia
authors.forename: N V
authors.initials: NV
authors.lastname: Kochergina
authors.forename: S V
authors.initials: SV
authors.lastname: Shiriaev
authors.forename: O G
authors.initials: OG
authors.lastname: Zimina
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D011471:Prostatic Neoplasms / Q000473:pathology; D011877:Radionuclide Imaging; D013324:Strontium / Q000627:therapeutic use*; D013326:Strontium Radioisotopes
chemical_list: D000700:Analgesics; D000970:Antineoplastic Agents; D013326:Strontium Radioisotopes; C025700:strontium chloride; D013324:Strontium